GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
37.79 +0.40  +1.07% NYSE Dec 9, 20:00 Delayed 2m USD

GlaxoSmithKline Cash from Financing (TTM):

-7.189B for Sept. 30, 2016
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

GlaxoSmithKline Historical Cash from Financing (TTM) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2016 -7.189B
June 30, 2016 -8.109B
March 31, 2016 -10.03B
Dec. 31, 2015 -10.86B
Sept. 30, 2015 -12.17B
June 30, 2015 -9.230B
March 31, 2015 -7.294B
Dec. 31, 2014 -8.877B
Sept. 30, 2014 -8.809B
June 30, 2014 -10.32B
March 31, 2014 -11.84B
Dec. 31, 2013 -9.815B
Sept. 30, 2013 -8.822B
June 30, 2013 -8.969B
March 31, 2013 -5.613B
Dec. 31, 2012 -5.310B
Sept. 30, 2012 -5.746B
June 30, 2012 -6.758B
March 31, 2012 -9.850B
Dec. 31, 2011 -9.993B
Sept. 30, 2011 -9.493B
June 30, 2011 -8.148B
March 31, 2011 -8.167B
Dec. 31, 2010 -8.588B
Sept. 30, 2010 -8.972B
   
June 30, 2010 -5.480B
March 31, 2010 -5.927B
Dec. 31, 2009 -4.345B
Sept. 30, 2009 -5.102B
June 30, 2009 -10.61B
March 31, 2009 -4.458B
Dec. 31, 2008 -9.077B
Sept. 30, 2008 -3.356B
June 30, 2008 -2.680B
March 31, 2008 -7.788B
Dec. 31, 2007 -3.488B
Sept. 30, 2007 -8.258B
June 30, 2007 -7.418B
March 31, 2007 -8.188B
Dec. 31, 2006 -8.832B
Sept. 30, 2006 -10.70B
June 30, 2006 -10.15B
March 31, 2006 -4.923B
Dec. 31, 2005 -5.301B
Sept. 30, 2005 -2.466B
June 30, 2005 -2.306B
March 31, 2005 -6.354B
Dec. 31, 2004 -6.242B
Sept. 30, 2004 -7.903B
June 30, 2004 -7.884B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Advertisement

GSK Cash from Financing (TTM) Benchmarks

Companies
Johnson & Johnson -8.091B
Merck & Co -9.356B
Pfizer -7.811B

GSK Cash from Financing (TTM) Range, Past 5 Years

Minimum -12.17B Sep 2015
Maximum -5.310B Dec 2012
Average -8.780B

GSK Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("GSK", "cash_financing_ttm")
  • Last 5 data points: =YCS("GSK", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.